{"id":23430,"date":"2025-04-13T17:39:45","date_gmt":"2025-04-13T17:39:45","guid":{"rendered":"https:\/\/researchchemicalstore.eu\/?post_type=product&p=23430"},"modified":"2025-10-23T00:51:16","modified_gmt":"2025-10-23T00:51:16","slug":"4-aco-mipt-fumarat","status":"publish","type":"product","link":"https:\/\/researchchemicalstore.eu\/is\/vara\/4-aco-mipt-fumarat\/","title":{"rendered":"4-AcO-MiPT f\u00famarat"},"content":{"rendered":"

4-AcO-MiPT f\u00famarat \u2013 V\u00f6rul\u00fdsing, notkun, \u00e1vinningur og gallar og algengar spurningar<\/span><\/span><\/strong><\/h3>\n

\ud83d\udd2cV\u00f6rul\u00fdsing<\/span><\/span><\/strong><\/h4>\n

4-AcO-MiPT (4-asetox\u00fd-N-met\u00fdl-N-\u00eds\u00f3pr\u00f3p\u00fdltryptam\u00edn) f\u00famarat er tilb\u00fai\u00f0 tryptam\u00edn sem er skyld efnum eins og psilocin (4-HO-DMT) og 4-AcO-DMT. \u00deetta er ranns\u00f3knarefni sem veri\u00f0 er a\u00f0 rannsaka vegna einstakra ge\u00f0virkra eiginleika \u00feess og m\u00f6gulegra notkunarm\u00f6guleika \u00ed taugav\u00edsindum.<\/span><\/span><\/p>\n

    \n
  • \n

    Efnaheiti:<\/span><\/span><\/strong> \u00a04-asetox\u00fd-N-met\u00fdl-N-\u00eds\u00f3pr\u00f3p\u00fdltryptam\u00edn f\u00famarat<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Sameindaform\u00fala:<\/span><\/span><\/strong> \u00a0C\u2081\u2087H\u2082\u2084N\u2082O\u2082 \u00b7 C\u2084H\u2084O\u2084<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Sameindamassi:<\/span><\/span><\/strong> \u00a0388,43 g\/m\u00f3l<\/span><\/span><\/p>\n<\/li>\n

  • \n

    \u00datlit:<\/span><\/span><\/strong> \u00a0Hv\u00edtt til lj\u00f3sbr\u00fant kristalla\u00f0 duft<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Hreinleiki:<\/span><\/span><\/strong> \u00a0\u226598% (sta\u00f0fest me\u00f0 HPLC og GC\/MS greiningu)<\/span><\/span><\/p>\n<\/li>\n

  • \n

    Leysni:<\/span><\/span><\/strong> \u00a0Leysanlegt \u00ed vatni, metan\u00f3li og etan\u00f3li<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

    \n

    \ud83d\udca1Notkunarsvi\u00f0smyndir af 4-AcO-MiPT f\u00famarati<\/span><\/span><\/strong><\/h3>\n

    4-AcO-MiPT f\u00famarat er\u00a0 <\/span><\/span>eing\u00f6ngu \u00e6tla\u00f0 til v\u00edsindaranns\u00f3kna<\/span><\/span><\/strong> \u00a0og ekki til manneldis. M\u00f6guleg notkunarsvi\u00f0 eru me\u00f0al annars:<\/span><\/span><\/p>\n

      \n
    1. \n

      S\u00e1lfr\u00e6\u00f0ilegar lyfjafr\u00e6\u00f0ilegar ranns\u00f3knir<\/span><\/span><\/strong> \u00a0\u2013 Ranns\u00f3kn \u00e1 ser\u00f3t\u00f3n\u00ednvirkum (5-HT\u2082A) \u00e1hrifum og breytingum \u00e1 skynjun.<\/span><\/span><\/p>\n<\/li>\n

    2. \n

      Samanbur\u00f0argreining<\/span><\/span><\/strong> \u00a0\u2013 Ranns\u00f3kn \u00e1 mismun \u00e1 tryptam\u00ednaflei\u00f0um (t.d. 4-AcO-DMT vs. 4-AcO-MiPT).<\/span><\/span><\/p>\n<\/li>\n

    3. \n

      D\u00fdraranns\u00f3knir (\u00ed st\u00fdr\u00f0u umhverfi)<\/span><\/span><\/strong> \u00a0\u2013 Athugun \u00e1 atferlis- og taugafr\u00e6\u00f0ilegum \u00e1hrifum.<\/span><\/span><\/p>\n<\/li>\n

    4. \n

      Ranns\u00f3knir \u00e1 vi\u00f0takabindingu<\/span><\/span><\/strong> \u00a0\u2013 In vitro pr\u00f3fanir \u00e1 milliverkunum vi\u00f0 ser\u00f3t\u00f3n\u00edn og \u00f6nnur taugabo\u00f0efnakerfi.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

      \n

      \u26a0\ufe0f\u00d3kostir og \u00e1h\u00e6tta<\/span><\/span><\/strong><\/h3>\n
        \n
      • \n

        S\u00e1lfr\u00e6\u00f0ileg \u00e1hrif<\/span><\/span><\/strong> \u00a0\u2013 Getur valdi\u00f0 ofskynjunum ef \u00fea\u00f0 er nota\u00f0 \u00e1 rangan h\u00e1tt.<\/span><\/span><\/p>\n<\/li>\n

      • \n

        \u00d3fullkomnar uppl\u00fdsingar um eitur\u00e1hrif<\/span><\/span><\/strong> \u00a0\u2013 Langt\u00edma\u00f6ryggi er ekki a\u00f0 fullu \u00feekkt.<\/span><\/span><\/p>\n<\/li>\n

      • \n

        N\u00e1kv\u00e6mur skammtur nau\u00f0synlegur<\/span><\/span><\/strong> \u00a0\u2013 L\u00e1gir skammtar (5-15 mg) geta haft sterk \u00e1hrif.<\/span><\/span><\/p>\n<\/li>\n

      • \n

        M\u00f6gulegar aukaverkanir<\/span><\/span><\/strong> \u00a0\u2013 Kv\u00ed\u00f0i, rugl, \u00f3gle\u00f0i e\u00f0a hra\u00f0sl\u00e1ttur.<\/span><\/span><\/p>\n<\/li>\n

      • \n

        L\u00f6gleg sta\u00f0a<\/span><\/span><\/strong> \u00a0\u2013 L\u00f6g um notkun \u00ed sumum l\u00f6ndum (athugi\u00f0 gildandi l\u00f6g).<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

        \n

        \ud83d\udccaR\u00e1\u00f0lag\u00f0ur skammtur (eing\u00f6ngu til ranns\u00f3kna)<\/span><\/span><\/strong><\/h3>\n
        \n\n\n\n\n\n\n
        Ums\u00f3kn<\/span><\/span><\/th>\nSkammtur (mg)<\/span><\/span><\/th>\nLeysiefni<\/span><\/span><\/th>\n<\/tr>\n<\/thead>\n
        Ranns\u00f3knir in vitro<\/span><\/span><\/td>\n1-5<\/span><\/span><\/td>\nEima\u00f0 vatn \/ etan\u00f3l<\/span><\/span><\/td>\n<\/tr>\n
        D\u00fdratilraunir*<\/span><\/span><\/td>\n0,1-0,3 mg\/kg<\/span><\/span><\/td>\nL\u00edfe\u00f0lisfr\u00e6\u00f0ileg saltlausn<\/span><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

        *Alltaf framkv\u00e6mt innan si\u00f0fer\u00f0ilega vi\u00f0urkennds ranns\u00f3knarramma.<\/span><\/span><\/p>\n

        \n

        \u2753Algengar spurningar (FAQs)<\/span><\/span><\/strong><\/h3>\n

        1. Er 4-AcO-MiPT l\u00f6glegt \u00ed Hollandi?<\/span><\/span><\/strong>
        \n \u00dea\u00f0 g\u00e6ti falli\u00f0 undir\u00a0 <\/span><\/span>\u00d3p\u00eduml\u00f6gin<\/span><\/span><\/strong> , allt eftir t\u00falkun. Leiti\u00f0 r\u00e1\u00f0a hj\u00e1 l\u00f6gfr\u00e6\u00f0ingi til a\u00f0 f\u00e1 frekari uppl\u00fdsingar.<\/span><\/span><\/p>\n

        2. Hvernig er \u00fea\u00f0 fr\u00e1brug\u00f0i\u00f0 4-AcO-DMT?<\/span><\/span><\/strong>
        \n 4-AcO-MiPT b\u00fd\u00f0ur upp \u00e1 \u00f6rl\u00edti\u00f0 mildari og \u201cloftmeiri\u201d upplifun samanbori\u00f0 vi\u00f0 4-AcO-DMT, me\u00f0 hugsanlega meiri skynjunarb\u00e6tingu.<\/span><\/span><\/p>\n

        3. Hvernig \u00e6tti a\u00f0 geyma \u00fea\u00f0?<\/span><\/span><\/strong>
        \n Geymi\u00f0 \u00ed\u00a0 <\/span><\/span>loft\u00fe\u00e9tt, d\u00f6kk \u00edl\u00e1t<\/span><\/span><\/strong> , vi\u00f0 hitastig undir 25\u00b0C og vari\u00f0 gegn raka.<\/span><\/span><\/p>\n

        4. Eru einhverjar h\u00e6ttulegar milliverkanir til sta\u00f0ar?<\/span><\/span><\/strong>
        \n J\u00e1, for\u00f0astu samsetningar me\u00f0\u00a0 <\/span><\/span>MAO-hemlar, SSRI-lyf, \u00f6rvandi lyf<\/span><\/span><\/strong> \u00a0, og \u00f6nnur ser\u00f3t\u00f3n\u00ednvirk efni (h\u00e6tta \u00e1 ser\u00f3t\u00f3n\u00ednheilkenni).<\/span><\/span><\/p>\n

        5. Er ranns\u00f3knarsk\u00fdrsla tilt\u00e6k?<\/span><\/span><\/strong>
        \n J\u00e1, a\u00a0 <\/span><\/span>COA (greiningarvottor\u00f0)<\/span><\/span><\/strong> \u00a0me\u00f0 HPLC og massagreiningarg\u00f6gnum fylgja kaup.<\/span><\/span><\/p>\n

        \n

        \ud83d\udd0eNi\u00f0ursta\u00f0a<\/span><\/span><\/strong><\/h3>\n

        4-AcO-MiPT f\u00famarat er \u00e1hugavert ranns\u00f3knarefni me\u00f0 m\u00f6guleika \u00e1 v\u00edsindalegum notkunum, en vegna ge\u00f0virkra eiginleika \u00feess \u00e6tti \u00fea\u00f0 a\u00f0...\u00a0 <\/span><\/span>a\u00f0eins nota vi\u00f0 st\u00fdr\u00f0ar ranns\u00f3knarstofua\u00f0st\u00e6\u00f0ur<\/span><\/span><\/strong> \u00a0.<\/span><\/span><\/p>\n

        \u26a0\ufe0f\u00a0Mikilv\u00e6gt:<\/span><\/span><\/strong> \u00a0\u00deessi vara er\u00a0 <\/span><\/span>ekki til manneldis<\/span><\/span><\/strong> \u00a0og \u00e6tti a\u00f0 me\u00f0h\u00f6ndla me\u00f0 var\u00fa\u00f0.<\/span><\/span><\/p>","protected":false},"excerpt":{"rendered":"

        4-AcO-MiPT fumarate properties<\/span><\/span><\/h3>\n

        Synonym:<\/span><\/span><\/strong> 4-acetoxy-N-methyl-N-isopropyltryptamine fumarate <\/span><\/span>
        \nCAS Number:<\/span><\/span><\/strong> 1024612-25-6 <\/span><\/span>
        \nFormula:<\/span><\/span><\/strong> 3-[2-(methyl(isopropyl)amino)ethyl]-1H-indol-4-yl acetate fumarate <\/span><\/span>
        \nMolar mass:<\/span><\/span><\/strong> 390.4 g\/mol <\/span><\/span>
        \nPurity:<\/span><\/span><\/strong> >97%<\/span><\/span><\/p>\n","protected":false},"featured_media":28682,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[538,381],"product_tag":[326],"class_list":["post-23430","product","type-product","status-publish","has-post-thumbnail","product_cat-4-aco-mipt","product_cat-tryptamines","product_tag-nl","first","instock","taxable","shipping-taxable","purchasable","product-type-variable"],"_links":{"self":[{"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/product\/23430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/comments?post=23430"}],"version-history":[{"count":5,"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/product\/23430\/revisions"}],"predecessor-version":[{"id":28078,"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/product\/23430\/revisions\/28078"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/media\/28682"}],"wp:attachment":[{"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/media?parent=23430"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/product_brand?post=23430"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/product_cat?post=23430"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/is\/wp-json\/wp\/v2\/product_tag?post=23430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}